Lemaitre Vascular, Inc.
A maker of medical devices for vascular surgery, headquartered outside Boston. Its products — including the UniFit graft and Valvulotome — help surgeons treat conditions like peripheral artery disease and maintain dialysis access, used by doctors in hospitals around the world. The company takes its name from its founder, George LeMaitre, a surgeon who built the business around devices he designed for the operating room.
Granted 185.5K · Sold 924.5K
Granted 25.3K
Granted 46.8K · Sold 37.0K
Granted 34.3K · Sold 30.7K
Granted 23.3K · Sold 20.5K
Granted 5.6K · Sold 13.4K
Granted 10.3K · Sold 15.0K
Granted 15.7K · Sold 17.9K
Granted 3.8K · Sold 1.5K
Granted 2.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| LeMaitre George WChairman and CEO, Director · 114 transactions | — | 2.93M | 185.5K | — | 924.5K |
| O'Connor John JamesDirector · 26 transactions | +28.3% | 62.8K | 25.3K | — | — |
| Pellegrino Joseph P JRDirector · 53 transactions | +93.5% | 15.0K | 46.8K | — | 37.0K |
| Roberts David BPresident and Director, Director · 70 transactions | -59.9% | 14.7K | 34.3K | — | 30.7K |
| Ross Bridget ADirector · 31 transactions | +45.7% | 9.0K | 23.3K | — | 20.5K |
| Jasinski Lawrence JDirector · 28 transactions | -34% | 7.8K | 5.6K | — | 13.4K |
| Roush John ADirector · 26 transactions | — | 4.3K | 10.3K | — | 15.0K |
| Kamke Trent GSenior V. P., Operations · 65 transactions | -28% | 3.7K | 15.7K | — | 17.9K |
| Shadan MarthaDirector · 21 transactions | +399.3% | 3.0K | 3.8K | — | 1.5K |
| LeBlanc Dorian PaulChief Financial Officer · 4 transactions | — | 2.3K | 2.4K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -1.06M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.